Produktinformation
Canagliflozin D4 is a synthetic compound that inhibits the SGLT2 transporter and increases the renal excretion of glucose. Canagliflozin D4 is used in the treatment of type 2 diabetes mellitus and is marketed as Invokana. Canagliflozin D4 is a racemic mixture of two enantiomers, with (S)-canagliflozin being more potent than (R)-canagliflozin. The reaction monitoring technique was used to monitor the production of metformin from canagliflozin D4 by extraction with diethyl ether. A validated method for quantification and monitoring was developed using deuterated water for flow rate linearity optimization. This method was applied to plasma samples obtained from healthy Indian subjects who were administered canagliflozin D4 at variable doses over 24 hours. The pharmacokinetic parameters were determined for each subject, resulting in an optimization of this drug dose range.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FC146109 Canagliflozin D4
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
